CXCL16 and Cowden disease: Thus, multiple lines of evidence suggest that the CXCL16-CXCR6 system may play an important role in colonic inflammation and could be a therapeutic target for CD [5], although the expression profile of CXCR6 on the colitogenic CD4+ T cells remains to be characterized.